Cargando…

Identification of TRIM56 as a Potential Biomarker for Lung Adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD) is the primary subtype of human lung cancer. The effectiveness of treatment and long-term survival of patients with LUAD are current suboptimal. Tripartite motif containing 56 (TRIM56) is a member of the TRIM protein family that have functions predominantly in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Kun, Sui, Yingli, Fu, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940991/ https://www.ncbi.nlm.nih.gov/pubmed/33707970 http://dx.doi.org/10.2147/CMAR.S288111

Ejemplares similares

The Functions of TRIM56 in Antiviral Innate Immunity and Tumorigenesis
por: Fu, Lin, et al.
Publicado: (2023)

Exosomal circZNF451 restrains anti-PD1 treatment in lung adenocarcinoma via polarizing macrophages by complexing with TRIM56 and FXR1
por: Gao, Jian, et al.
Publicado: (2022)

Identification of potential biomarkers for lung adenocarcinoma
por: Sayeeram, Deepak, et al.
Publicado: (2020)

TRIM29 as a Novel Biomarker in Pancreatic Adenocarcinoma
por: Sun, Hongli, et al.
Publicado: (2014)

TRIM28 is a distinct prognostic biomarker that worsens the tumor immune microenvironment in lung adenocarcinoma
por: Liu, Jie, et al.
Publicado: (2020)

Regulation of estrogen signaling and breast cancer proliferation by an ubiquitin ligase TRIM56
por: Xue, Min, et al.
Publicado: (2019)

Identification of TLRs as potential prognostic biomarkers for lung adenocarcinoma
por: Ying, Junjie, et al.
Publicado: (2023)

Identification of nine microRNAs as potential biomarkers for lung adenocarcinoma
por: Ren, Zhi‐Peng, et al.
Publicado: (2019)

Identification of potential key molecular biomarkers in lung adenocarcinoma by bioinformatics analysis
por: Guo, Pengyi, et al.
Publicado: (2022)

TRIM56-mediated monoubiquitination of cGAS for cytosolic DNA sensing
por: Seo, Gil Ju, et al.
Publicado: (2018)

TRIM56 Suppresses Multiple Myeloma Progression by Activating TLR3/TRIF Signaling
por: Chen, Ying, et al.
Publicado: (2018)

Elevated TRIM23 expression predicts cisplatin resistance in lung adenocarcinoma
por: Zhang, Youwei, et al.
Publicado: (2020)

Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma
por: Yuan, Yinjiao, et al.
Publicado: (2023)

TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein
por: Yang, Xu, et al.
Publicado: (2022)

Identification of Three lncRNAs as Potential Predictive Biomarkers of Lung Adenocarcinoma
por: Jin, Donghui, et al.
Publicado: (2020)

Identification of microRNAs as potential biomarkers for lung adenocarcinoma using integrating genomics analysis
por: Peng, Zhuo, et al.
Publicado: (2017)

Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma
por: Luo, Lianxiang, et al.
Publicado: (2021)

Identification of urine biomarkers associated with lung adenocarcinoma
por: Wang, Weiwei, et al.
Publicado: (2017)

Identification of lncRNAs associated with T cells as potential biomarkers and therapeutic targets in lung adenocarcinoma
por: SUN, LU, et al.
Publicado: (2023)

CBX7, a Potential Prognostic Biomarker in Lung Adenocarcinoma
por: Yang, Yanlong, et al.
Publicado: (2021)

Screening and identification of biomarkers associated with the diagnosis and prognosis of lung adenocarcinoma
por: Wang, Yanyun, et al.
Publicado: (2020)

TRIM2 directly deubiquitinates and stabilizes Snail1 protein, mediating proliferation and metastasis of lung adenocarcinoma
por: Lin, Zhaoxian, et al.
Publicado: (2020)

hsa_circ_0000729, a potential prognostic biomarker in lung adenocarcinoma
por: Li, Shicheng, et al.
Publicado: (2018)

TRIM59: A potential diagnostic and prognostic biomarker in human tumors
por: Jin, Zheng, et al.
Publicado: (2021)

TRIM56 coiled-coil domain structure provides insights into its E3 ligase functions
por: Lou, Xiaohua, et al.
Publicado: (2023)

TRIM21‑a potential biomarker for the prognosis of thyroid cancer
por: Wu, Zhen, et al.
Publicado: (2022)

Identification of Extracellular Matrix Signatures as Novel Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Zeng, Zhen, et al.
Publicado: (2022)

Overexpression of hsa_circ_0001715 is a Potential Diagnostic and Prognostic Biomarker in Lung Adenocarcinoma
por: Lu, Guo-jun, et al.
Publicado: (2020)

Identification and validation of novel biomarker TRIM8 related to cervical cancer
por: Zhang, Li, et al.
Publicado: (2022)

Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19
por: Tavakoli, Rezvan, et al.
Publicado: (2023)

Identification of ubiquinol cytochrome c reductase hinge (UQCRH) as a potential diagnostic biomarker for lung adenocarcinoma
por: Gao, Feng, et al.
Publicado: (2016)

Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis
por: Sui, Yingli, et al.
Publicado: (2021)

Identification of Cigarette Smoking-Related Novel Biomarkers in Lung Adenocarcinoma
por: Zhang, Yuan, et al.
Publicado: (2022)

Serum Exosomal miR-1290 is a Potential Biomarker for Lung Adenocarcinoma
por: Wu, Yining, et al.
Publicado: (2020)

Identification of GPD1L as a Potential Prognosis Biomarker and Associated with Immune Infiltrates in Lung Adenocarcinoma
por: Fan, Zhengyang, et al.
Publicado: (2023)

The role of TRIM51 as a multipurpose biomarker in melanoma
por: Lim, Byungho
Publicado: (2021)

Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma
por: Daugaard, Iben, et al.
Publicado: (2016)

Identification of a m(6)A-related ferroptosis signature as a potential predictive biomarker for lung adenocarcinoma
por: Li, Dongdong, et al.
Publicado: (2023)

Screening microRNAs as potential prognostic biomarkers for lung adenocarcinoma
por: Dai, Hongshuang, et al.
Publicado: (2023)

Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma
por: Kajiura, Koichiro, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_du62gk10gt37a7847ihfnfolt6